Immunotherapy - PD-1 and Beyond - Melanoma Education Symposium, Patrick Ott MD PhD

Dr. Patrick Ott, Assistant Orofessor of Medicine at Harvard Medical School, Dana Farber Cancer Center speaks on the future of immunotherapy and clinical trials for metastatic melanoma at the 2013 Melanoma Education Symposium hosted by The Angeles Clinic Foundation and AIM at Melanoma

[@thegbstore]

Great talk,thank you :)

[@DaveSolazzo]

Amazing!

[@dgr8flav]

Some of your best scientists are uncomfortable public speakers.

[@leilaniermeijer5520]

Do not speak in Public anymore. How nerves & uncomfortable you make everyone

[@mariosola1]

You probably don't understand the impact that CTLA-4 and PD-1/PDL-1 are having on cancer treatment. Otherwise someone more informed in this field would realize the significance of what he is talking about and would never type something like "Do not speak in public".